
Pharmacally
Plantar Fibromatosis
Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.
Latest in Plantar Fibromatosis
Clinical TrialsKeenova’s XIAFLEX Delivers Positive Phase 3 Results in Plantar FibromatosisKeenova Therapeutics reported positive Phase 3 results for XIAFLEX in plantar fibromatosis, with the pivotal EN3835-309 trial meeting its primary and key secondary endpoints.Fact-Checked
Explore more
Health TidingsIndustry, pipeline and company news.
RegulatoryApprovals, policy and agency decisions.
ResearchPeer-reviewed studies and scientific breakthroughs.
Drug FinderLook up any drug: uses, dosing and safety.
From the HistoryLandmark moments in pharmaceutical history.
LatestEvery new story, as soon as it is published.